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The carboxyl-terminal portion of simian virus 40 large T antigen is essential for productive infection of CV-1
and CV-lp green monkey kidney cells. Mutant dlA2459, lacking 14 base pairs at 0.193 map units, was positive
for viral DNA replication, but unable to form plaques in CV-lp cells (J. Tornow and C. N. Cole, J. Virol.
47:487-494, 1983). In this report, the defect of dlA2459 is further defined. Simian virus 40 late mRNAs were
transcribed, polyadenylated, spliced, and transported in dlA2459-infected cells, but the level of capsid proteins
produced in infected CV-1 green monkey kidney cells was extremely low. dlA2459 large T antigen lacks those
residues known to be required for adenovirus helper function, and the block to productive infection by dIA2459
occurs at the same stage of infection as the block to productive adenovirus infection of CV-1 cells. These results
suggest that the adenovirus helper function is required for productive infection by simian virus 40. Mutant
dlA2459 was able to grow on the Vero and BSC-1 lines of African green monkey kidney cells. Additional
mutants affecting the carboxyl-terminal portion of large T were prepared. Mutant inv2408 contains an
inversion of the DNA between the BamHI and Bcll sites (0.144 to 0.189 map units). This inversion causes
transposition of the carboxyl-terminal 26 amino acids of large T antigen and the carboxyl-terminal 18 amino
acids of VP1. This mutant was viable, even though the essential information absent from dlA2459 large T
antigen has been transferred to the carboxyl terminus of VP1 of inv2408. The VP1 polypeptide carrying this
carboxyl-terminal portion of large T could overcome the defect of dlA2459. This indicates that the carboxyl
terminus of large T antigen is a separate and separable functional domain.

The simian virus 40 (SV40) large T antigen performs many
functions during lytic and transforming infections by SV40.
It is involved in the initiation of viral DNA synthesis (10, 61),
triggers host DNA replication (31), is involved in the autoregulation of the level of its own mRNA (2, 52, 63), and is
required for both the initiation and maintenance of malignant
transformation of nonpermissive cells (34, 35, 62). In addition, it provides a function that permits the growth of human
adenoviruses in monkey cells (14, 30, 50). The polypeptide
contains both DNA-binding (32, 64) and ATPase (11, 28)
activities.
Analysis of the biochemical properties of mutants with
deletions in the A gene, encoding large T antigen, indicates
that sequences between 0.50 and 0.43 map units are required
for specific binding to the SV40 origin of DNA replication
(12, 48, 56), and sequences in the vicinity of 0.30 map units
(m.u.) (11) are associated with ATPase activity. Thus, the
polypeptide contains multiple functional domains. It is likely
that both of these activities must exist within each active T
antigen polypeptide, since complementation between binding-competent, ATPase-defective and ATPase-positive,
binding-defective mutants has not been observed (65; J.
Tornow, R. Clark, C. Cole, and R. Tjian, and C. N. Cole,
manuscript in preparation), even though oligomeric forms of
T antigen are found in virus-infected cells (8, 19, 20, 49).

There is considerable homology between the large T
antigens of SV40 and polyomavirus, but each contains a
region not found in the other large T antigen (Fig. 1) (24, 27,
51, 58). The carboxyl-terminal 113 amino acids of SV40 large
T (residues 596 through 708, encoded by 0.25 through 0.174
m.u.) is the only portion of the polypeptide showing no
homology to any portion of polyomavirus large T. This
portion of large T is known to be involved in providing the
adenovirus helper function (23, 47). In addition, infected
cells contain a 64-base RNA that is complementary to early
mRNA and that is encoded by sequences near map position
0.21 (1, 41). Many completely viable mutants of SV40 do not
produce this small RNA (1, 47; M. Polvino-Bodnar, Ph.D.
thesis, Yale University, New Haven, Conn., 1983), suggesting that it does not play an important role during the lytic
infection cycle. Finally, this portion of the early region
contains an alternate open reading frame of 95 condons.
Almost all of this alternative reading frame is deleted in one
or another viable mutant genome (15, 22, 25, 44, 45, 47, 66),
suggesting that it also does not play an important role. There
is no evidence that it is ever used. The role played by this
portion of large T antigen during the normal SV40 infection
cycle has remained a mystery.
We described previously a set of mutants with deletions at
DdeI sites in the early region of SV40 (65, 66). One of these
mutants, dlA2459, with a 14-base-pair (bp) deletion at 0.193
m.u., is nonviable, but differs from most nonviable T antigen
mutants in its ability to catalyze the replication of SV40
DNA (66). This mutant defines a function that is provided by
SV40 large T and that is required after the onset of viral
DNA replication. The function defective in dlA2459 can be
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FIG. 1. Comparison of the early regions c)f SV40 and polyoma-

virus. The regions that show homology hav,e the same numbers.
Unique regions (polyomavirus region 3 and SV4o region 5) have
different numbers. Homology was determined
58). Region
of published sequence information for SV40 ( 24, 27,
1 corresponds to the NH2-terminal regions sshared by all pa ovaunique portion of
virus tumor antigens. Region 2 corresponds tc
small t antigen; the polyomavirus middle t ant igen also contains this
amino acid sequence. Region 3 encodes tIhe unique portion of
polyomavirus middle T antigen and, in a ditfferent reading frame,
part of large T antigen. Region 4 encodes that part of large T antigen
wherein map almost all of the tsA SV40 aand tsa polyomavirus
mutants. Region 5 encodes that portion of SV40 large T antigen
which has no homology to polyomavirus larg
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provided by group A mutants, which c:ontain either point
mutations or deletions that are multiples of 3 bp (65). Thus,
mutants able to express the carboxyl-Iterminal domain of
large T are able to complement dIA245119 intracistronically.
This indicates that some critical functioni is provided by this
portion of large T antigen and that thiis function can be
performed by T-antigen molecules defec tive in other T-antigen properties.
In this report, the defect of dlA2459 is ifurther defined. The
mutant was positive for the synthesis anId processing of late
mRNA, but the level of capsid proteins found in infected
CV-1 green monkey cells was drastically reduced. This
defect resembles that of human adenoviruses in monkey
cells (26, 37). Since dIA2459 large T antigen lacks those
residues known to be required for helper function, these
results suggest that adenovirus helper function is required
for productive infection by SV40. Mutant dIA2459 is a host
range mutant, since it is able to form plaques on BSC-1 and
Vero green monkey kidney monolayers.
Additional mutations affecting the carboxyl-terminal portion of large T are also described. In one, inv2408, the
carboxyl terminal 18 amino acids of VP1 and the carboxylterminal 26 amino acids of large T antigen were exchanged.
This mutant was viable. The VP1-T antigen fusion protein of
this mutant can overcome the defect of dIA2459. This
indicates that the portion of large T that provides the late
function defined by dlA2459 is a separate and separable
functional domain.
MATERIALS AND METHODS
Construction of SV40 mutants. The construction of mutants dlA2459, dlA2411, and dIA2420 has been described
previously (65, 66). Mutant inv2408 was constructed (Fig. 2)

by digesting SV40 viral DNA to completion with BamHI and
BcIl, yielding fragments of 237 and 5,006 bp. Although these
two restriction endonucleases recognize different sequences,
each produces 5'-GATC-3' termini at its cleavage site. These
fragments were ligated with T4 DNA ligase at a DNA con-

centration of 20 ,ug/ml. Subsequently, the DNA was digested
with EcoRI and ligated with EcoRI-digested pBR322. The
ligation reaction contained 10 ,ug of each DNA per ml. The
HB101 strain of Escherichia coli was transfected with this
DNA, and colonies were selected on plates containing ampicillin (20,ug/ml). Minilysate DNA preparations were
screened by digestion with EcoRI, BamHI, and Sau3AI.
inv2408 contained two sites recognized by EcoRI and a
single BamHI site and produced the same Sau3AI digestion
pattern as did wild-type SV40 cloned into the EcoRI site of
pBR322.
dl(inv)2408E was constructed by combining the large
ApaI-KpnI fragment of inv2408 (containing the entire early
region and including the inversion) with the small ApaI-KpnI
fragment of dlBC865 (containing most of the late region and
covering the deletion at the EcoRI site) (Fig. 3). The ligation
mixture was then extracted twice with phenol-chloroformisoamyl alcohol (25:24:1) and four times with ether, ethanol
precipitated, and dissolved in 10 rmM Tris-chloride (pH
7.5)-i mM EDTA-10 mM NaCl. The DNA was digested
with EcoRV and ligated with an equimolar concentration of
EcoRV-digested pBR322 DNA, at a total DNA concentration of 20 p.g/ml. Insertion of DNA into the EcoRV site of
pBR322 inactivates the tetracycline resistance gene. After

transfection, colonies were selected on plates containing
ampicillin (20 ,ug/ml) and screened to identify those colonies
sensitive to tetracycline (15 ,ug/ml).
dl(inv)2408L was constructed by combining the 946-bp
ApaI-PstI fragment of inv2408 (0.091 to 0.271 m.u. and
including the inversion), the 2,004-bp PstI-KpnI fragment of
dlA1209 (0.271 to 0.716 m.u. and covering the deletion
between 0.587 and 0.650 m.u.) and the 6,326-bp KpnI-ApaI
fragment of pCC2, which contains the complete wild-type
SV40 genome inserted into the EcoRI site of pBR322. For
the ligation, an equimolar concentration of the three fragments and a total DNA concentration of 25 ,ug/ml were used.
Cells, viruses, and plasmids. The growth of CV-1 and
CV-lp cells has been described previously (47). The same
RI
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FIG. 2. Construction of SV40 mutant inv2408 and its insertion
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protocols were used for growth of BSC-1 and Vero cells,
which are also African green monkey kidney lines. All were
maintained in Dulbecco modified Eagle medium (DMEM)
containing 5% fetal bovine serum (FBS). Our wild-type
strain of SV40 (WT830) was the small-plaque strain originally characterized by Takemoto et al. (60). Wild-type SV40
DNA was digested with EcoRI and cloned into the EcoRI
site of pBR322.
All mutants were maintained as recombinant plasmids
(inserted into pBR322) in the HB101 strain of E. coli.
Previously described methods were used for bacterial transformations (40) and for the preparation of minilysates (7) and
purified plasmid DNA (13). All DNA preparations were
purified by equilibrium buoyant density centrifugation in
gradients containing CsCl and ethidium bromide (300 ,ug/ml).
Mutants dlBC865 (9), dlA1209, and dlE1226 (15), and tsA1642
(16) were cloned in the BamHI site of pBR322. All other
mutants except dl(inv)2408E were cloned in the EcoRI site

of pBR322; dl(inv)2408E was cloned in the EcoRV site of
pBR322.
Transfection of eucaryotic cells. Plasmid DNA was first
digested with either BamHI, EcoRI, or EcoRV to separate
bacterial and viral sequences. This DNA was then ligated at
low concentration (5 ,ug/ml) with T4 DNA ligase to recircularize the viral DNA. Confluent monolayers of CV-1 cells
were incubated in Tris-buffered saline (25 mM Tris-chloride
[pH 7.5], 137 mM NaCl, 5 mM KCI, 0.6 mM Na2HPO4, 0.05
mM MgCl2, 0.7 mM CaC12) containing 1 p,g of DNA per ml
and 500 ,ug of DEAE-dextran (5 x 105 daltons; Sigma
Chemical Co., St. Louis, Mo.) per ml for 30 to 45 miri at
37°C. Plates 100 mm in diameter received 0.6 to 1.0 mls of
this mixture, 60-mm plates received 0.2 to 0.3 ml, and 35-mm
plates received 0.1 to 0.2 ml. Cells were then washed twice
with Tris-buffered saline and incubated with DMEM containing 2% FBS and 100 ,uM chloroquine diphosphate (Sigma)
for 4 to 6 h at 37°C. The treatment with chloroquine
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FIG. 4. Si nuclease protection analysis of late mRNA produced
in dIA2459-infected cells. Total cytoplasmic RNA was prepared 72 h
after transfection. EcoRI-digested SV40 DNA was 3' end labeled
(A) or 5' end labeled (B) as described in the text. The DNA probes
were hybridized to 25 ,ug of RNA under conditions of DNA excess
at 47°C for 15 h. After S1 nuclease treatment, samples were
analyzed by electrophoresis in 1.4% alkaline agarose (30 mM
NaOH, 2.5 mM EDTA) gels. After electrophoresis, gels were fixed
in 7% trichloroacetic acid, dried, and exposed to Kodak XAR-5 film.
Lanes (A and B): 1, wild-type SV40; 2, dIA2411; 3, dIA2459; 4,
mock infected. In A, 5' end labeled, MboI-digested SV40 DNA
served for size markers; in B, 3' end labeled, Ddel-digested plasmid
containing SV40 inserted into the EcoRI site of pBR322 was used for
size markers.

diphosphate increases the percentage of cells expressing
transfected DNA from 1 to 2% to 40 to 60% (39). After the
chloroquine diphosphate treatment, the chloroquine-containing medium was replaced with DMEM containing 2% FBS,
and cells were incubated at 37°C.
Plaque assays and genetic complementation tests. Wild-type
and mutant DNAs were separated from bacterial and plasmid
sequences as described above. Confluent monolayers of
CV-lp, BSC-1, or Vero cells were transfected with three
different concentrations of each DNA (10, 1, and 0.1 ng per
60-mm plate) by using DEAE dextran as described by Mertz
and Berg (42). The cells were incubated under an agar
overlay containing DMEM, 1% Bacto-agar (Difco Laboratories, Detroit, Mich.), 4% FBS, and antibiotics for 10 to 12
days at 37°C (or other temperatures when temperature
sensitivity was being determined). Plaques were visualized
by staining with neutral red. Plaques were counted 24 h
later. To determine rates of plaque enlargement, averages
were determined for 50 plaques on a daily basis once plaques
had appeared.
Genetic complementation analyses were done in the same
way, except cells were cotransfected with dilutions of the
DNA to be tested and 10 ng of helper DNAs.
RNA analysis. Cytoplasmic RNA was extracted from
transfected CV-1 cells 48 to 72 h postinfection by the method
of White et al. (68) and analyzed by the S1 nuclease method
of Berk and Sharp (6) as described by Favaloro et al. (21).
Probes were end labeled at the EcoRI site of SV40 by using
either alpha[32P]deoxynucleoside triphosphates and the
Klenow fragment of DNA polymerase I (3' end-labeled
probes) or gamma[32P]ATP and polynucleotide kinase (5'
end-labeled probes).
Analysis of viral DNA replication. DNA replication was
analyzed after transfection of cultures of CV-1 cells in
60-mm dishes as described previously (47, 66).
Analysis of virus-specific proteins by immunoprecipitation.
At appropriate times after infection (indicated in figure
legends), cells were washed twice with Tris-buffered saline

and incubated for 1 h in DMEM lacking methionine and
containing 2% dialyzed FBS. This medium was removed and
replaced with DMEM lacking methionine and containing 2%
dialyzed FBS and 300 ,uCi of [35S]methionine per ml (0.5 ml
per 100-mm plate, 0.25 ml per 35-mm plate). The duration of
the labeling period was as indicated in the figure legends.
After the labeling period, cells were washed twice with
Tris-buffered saline, and protein extracts were prepared.
Ice-cold lysing buffer (0.15 M NaCl, 0.02 M Tris-chloride
[pH 8.0], 1% Nonidet P-40) was added to the cells (0.5 ml per
100-mm plate, 0.25 ml per 35-mm plate). Cells were incubated in the lysing buffer for 30 min at 4°C. Cells and buffer
were then scraped from the plates into Eppendorf tubes with
a rubber policeman. Tubes were spun in a microcentrifuge to
pellet the cellular debris, and the supernatant was removed
to another tube and stored at -70°C.
A 0.1-ml sample of extract was immunoprecipitated as
described previously (47). Either hamster antitumor serum
(lot 8-OOX from the National Institutes of Health), rabbit
antiserum against sodium dodecyl sulfate (SDS)-disrupted
virions, or monoclonal antibody was used to precipitate T
antigens or capsid proteins. Monoclonal antibody recognizing determinants in the carboxyl-terminal region of T antigen
was a gift from S. Tevethia. Samples were analyzed by
electrophoresis on SDS-polyacrylamide gels. After electrophoresis, gels were fixed in 50% methanol-10% acetic
acid-10% trichloroacetic acid, fluorographed with En3Hance
(New England Nuclear Corp., Boston, Mass.), dried, and
exposed to Kodak XAR-5 film for 1 to 5 days at -70°C.
Enzymes and Chemicals. Restriction endonucleases were
purchased from New England Biolabs (Beverly, Mass.), P-L
Biochemicals (Milwaukee, Wis.), or Boehringer Mannheim
(Indianapolis, Ind.) and used according to the instructions of
the supplier. T4 DNA ligase was purchased from Collaborative Research (Waltham, Mass.) or New England Biolabs,
T4 polynucleotide kinase was from New England Biolabs,
calf intestinal alkaline phosphatase was from Boehringer
Mannheim, Si nuclease was from P-L Biochemicals or
Boehringer Mannheim, and proteinase K was from Beckman
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TABLE 1. Complementation between dIA2459 and tsA1642"
Mutant no.
Mutant

dIBC865
dlA1209
d1A2411b
dlA2420b
d1A2416b
d1A2432b

dIA24lOb

dlA2433b

dlA2459b

dl(inv)2408E'

Location of
mutation (m.u.)

0 or 1.0
0.650 to 0.587
0.497
0.497
0.288
0.288
0.243
0.243
0.193

Plaques formed (PFU/,ug) by complementation with:
dIA2459
tsA1642
dIBC865

1 x 105

1.3 x 105

<103
9 X 104
<103
<103
6 x 104
<103
7 x 104
<103
<103

<103
<i0l

<103
<i0l
<103
<103
<10

1.1

X
9 X

105
104

<103
9 x 104

2.0
1.2
1.4
9.5
1.3
1.4
1.9

x 105
x 105
x 105
x

104

x 105

105
105
<103
x

X

a Monolayers of CV-lp cells were exposed to dilutions of mutant DNA and
10 ng of complementing mutant DNA. Plates were incubated at 37°C, and
plaques were counted 12 days after infection.
b
These mutants were constructed and characterized by Tornow and Cole
(5). Mutants dlA2411, dlA2432, and dIA2433 produce nearly full-sized large T
antigens, since a multiple of 3 bp is deleted. Mutants dlA2420, dIA2416,
dIA2410, and dIA2459 produce truncated large T antigens, since the deletions
are not multiples of 3 bp and therefore cause a shift in the translation reading
frame.
'
dl(inv)2408E contains an inversion of the BamHI-to-BclI fragment of
SV40 (0.144 to 0.189 m.u.) and the same deletion at the EcoRI site (0 or 1.0
m.u.) as mutant dlBC865.

Instruments Inc. (Fullerton, Calif.). All radiochemicals were
purchased from Amersham Corp. (Arlington Heights, Ill.).
RESULTS
The defect of dlA2459 affects a late stage of infection. SV40
mutant dIA2459 lacks 14 bp (nucleotides 2,785 through
2,798) at 0.193 m.u. (66). It directs the synthesis of a large T
antigen that lacks the carboxyl-terminal 35 amino acids.
Progeny viral DNA is synthesized in CV-1 cells transfected
with dIA2459 DNA (66). To determine whether the block to
productive infection by dlA2459 was at the level of late
mRNA transcription, the synthesis of late mRNA was
examined (Fig. 4).
CV-1 cells were transfected with dlA2459, dIA2411 (a
replication-defective group A mutant), or wild-type SV40
DNA. Total cytoplasmic RNA was isolated 72 h later and
analyzed by the Si nuclease mapping procedure (6, 21).
EcoRI-digested SV40 DNA was labeled at its 3' end. This
probe will be protected by all late mRNAs that extend
beyond the EcoRI site to the polyadenylation site for the late
mRNAs. Analysis of total cytoplasmic RNA prepared 72 h
after transfection demonstrated that dlA2459 (Fig. 4A, lane
3) produced as much late mRNA as did wild-type SV40 (Fig.
4A, lane 1). No late mRNA was detected in cells transfected
with dIA2411 DNA (Fig. 4A, lane 2) or mock-infected cells
(Fig. 4A, lane 4). To determine whether the block to dlA2459
infection was at the level of mRNA processing, another S1
nuclease protection experiment was performed with a probe
that was 5' end labeled at the EcoRI site. This probe will be
protected by that part of the late mRNAs that is between the
acceptor splice junctions and the EcoRI site. Both 16S and
19S late mRNAs were produced in dlA2459-infected cells
(Fig. 4B, lane 3) and the ratio of 16S/19S mRNAs was the
same as in wild type-infected cells (Fig. 4B, lane 1). The
probe was not protected by RNA prepared from either
mock-infected (Fig. 4B, lane 4) or dIA2411-infected (Fig. 4B,
lane 2) cells. Identical results were obtained when polyadenylated mRNA was used (data not shown). We conclude
that late mRNAs are synthesized, polyadenylated, spliced,
and transported in dlA2459-infected cells, and that the

419

abundance of these species is comparable to that of wildtype SV40 late mRNA. We have not yet examined the
structures of the leaders and the locations of splice donor
sites of dlA2459 late mRNAs.
To determine whether the block to productive infection by
dlA2459 was at the level of capsid protein synthesis, CV-1
cells were infected with dlA2459 or wild-type DNA or mock
infected and labeled 30 or 54 h later with [35S]methionine.
Extracts were prepared, immunoprecipitated with rabbit
anti-capsid protein antiserum or hamster anti-tumor antiserum, and analyzed by electrophoresis on SDSpolyacrylamide gels (Fig. 5). Although dlA2459 produces
almost as much large T antigen as the wild type at both times
(Fig. 5), the production of capsid protein VP1 is greatly
reduced, especially at 54 h after infection. VP2 and VP3
could not be detected in protein extracts of d1A2459-infected
cells. We conclude that dIA2459 does not form plaques in
CV-lp cells due to an inability to produce sufficient levels of
capsid proteins.
One other replication-competent group A mutant of SV40
has been described (16). Mutant tsA1642 produces viral
DNA, late mRNA, and capsid proteins at the nonpermissive
temperature, but does not form plaques. It is blocked at
some stage after capsid protein synthesis, perhaps in virion
morphogenesis. To determine whether tsA1642 and dIA2459
affected different functions of SV40 large T antigen, a
genetic complementation experiment was performed (Table
1). tsA1642 complemented the defect of dlA2459, but not the
defect of dlA2411. Therefore, dIA2459 and tsA1642 affect
different functions of large T antigen.
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virions, or tissue culture fluid containing a monoclonal antibody
directed against the carboxyl terminus of large T antigen. The
numbers at the left represent the positions of size markers (sizes in

kilodaltons).
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FIG. 7. Analysis of viral DNA replication in CV-1 cells infected
by wild-type SV40 or inv2408. Confluent monolayers of CV-1 cells
were transfected with wild-type SV40 or inv2408 DNA. Extracts
were prepared at various times after infection (1, 2, 3, or 5 days).
Cells were washed with Tris-buffered saline, and 0.3 ml of extraction buffer (0.01 M Tris-chloride, [pH 7.5], 0.6% SDS, 0.01 M
EDTA); 0.1 ml of 5 M NaCl, and 0.025 ml of a solution (10 mg/ml)
of proteinase K were added to each plate. Each plate also received
0.015 ml of 3H-labeled M13 phage replicative-form DNA (approximately 30,000 cpm). The plates were incubated at 37°C overnight.
The next day, lysates were scraped into Eppendorf tubes and stored
at 4°C overnight. The next day, tubes were spun for 50 min at 18,000
rpm in a refrigerated Sorvall centrifuge. Supernatants were removed, phenol extracted once, and precipitated by the addition of 2
volumes of ethanol. After centrifugation, DNA pellets were dissolved in 0.1 ml of 10 mM Tris-chloride (pH 7.5)-l mM EDTA-10
mM NaCl. A sample of each preparation was precipitated with
trichloroacetic acid to determine the percent recovery of the 3H-labeled phage DNA. Samples containing equal numbers of counts
were subjected to electrophoresis in a 1% agarose gel in 89 mM
Tris-chloride (pH 8.2-89 mM boric acid-2.5 mM EDTA. After
electrophoresis, DNA in the gel was depurinated by soaking the gel
in 0.25 M HCl for two 15-min periods, denatured by washing with
0.5 M NaOH and 1.5 M NaCl for two 30-min periods, and neutralized by washing with 0.5 M Tris-chloride (pH 7.5)-3 M NaCl for two
30-min periods. The DNA was then transferred to nitrocellulose
(BA85; Schleicher & Schuell Co., Keene, N.H.) by the method of
Southern (59). 32P-labelled probe (specific activity, 108 cpm/,ug) was
prepared by nick translation of a plasmid containing SV40 inserted
into the EcoRI site of pBR322 (54). The filter was prehybridized (8
h) and hybridized with probe (15 h) in standard buffers containing
50% formamide at 42°C. The filter was washed twice with 2x SSC
(lx SSC is 0.15 M NaCl, 0.015 M sodium citrate)-0.1% SDS at
room temperature for 15 min and twice with 0.2x SSC-0.1% SDS at
55°C for 15 min. The filter was dried in air and exposed to Kodak
XAR-5 film. The marker lanes (M) contained 20 ng of SV40 DNA
included to monitor the evenness of transfer to nitrocellulose.

Viability is retained when the information absent from
dlA2459 large T antigen is transposed to the carboxyl terminus
of VP1. inv2408 is a viable SV40 mutant in which the
carboxyl terminal 26 amino acids of large T antigen are
transferred to VP1 and the carboxyl terminal 18 amino acids
of VP1 are transferred to large T antigen. This mutant was
constructed by inverting the small (237-bp) BamHI-to-BclI
fragment of SV40. That these domains have actually been
exchanged was confirmed by immunoprecipitation of
[35S]methionine-labeled protein extracts from wild type- and
inv2408-infected cells with appropriate antisera or monoclonal antibodies (Fig. 6). When antitumor serum was used,
wild-type large T antigen was immunoprecipitated and both
large T and VP1 were immunoprecipitated from inv2408infected cells, indicating that inv2408 VP1 contains large
T-antigen information. When a monoclonal antibody di-

rected against the carboxyl-terminal portion of large T was
used, large T was immunoprecipitated from wild type-infected cells, but not from inv2408-infected cells. Instead,
inv2408 VP1 was immunoprecipitated, indicating that it
carried information from the carboxyl terminus of large T
antigen. When antiserum prepared against SDS-disrupted
SV40 virions was used, the three capsid proteins, VP1, VP2,
and VP3, were immunoprecipitated from wild type-infected
cell extracts. The same three polypeptides and large T
antigen were immunoprecipitated from inv2408-infected
cells, indicating that the inv2408 large T antigen carried
capsid protein antigenic information.
Plaques formed in CV-lp cells transfected with inv2408
DNA with the same efficiency (PFU per microgram) as with
wild-type SV40. However, the plaques appeared later and
enlarged more slowly than did wild-type SV40 plaques. The
kinetics of progeny DNA synthesis in inv2408-infected cells
was indistinguishable from that of wild-type SV40 (Fig. 7).
This suggests that the slower rate of plaque enlargement
reflects either a slower rate of assembly of inv2408 progeny,
production of a smaller number of inv2408 virions, or
reduced specific infectivity of inv2408 virions.
Construction and analysis of SV40 mutants expressing only
one of the two fusion proteins expressed by inv2408. In
inv2408, that portion of large T antigen missing from the
large T of dlA2459 was fused to the carboxyl terminus of
VP1. Since inv2408 was a viable mutant, this suggested that
this information was able to function even when separated
from the remainder of large T antigen. Two derivatives of
inv2408 were constructed which expressed only one of two
fusion polypeptides produced by inv2408 (large T with the
carboxyl terminus of VP1 and VP1 with the carboxyl terminus of large T). These derivatives were constructed (Fig. 3)
by replacing portions of the inv2408 genome with DNA
fragments derived from other SV40 mutants.
dlBC865 is a nonviable SV40 mutant with a deletion at the
EcoRI site (9), which is located near the beginning of the
coding region for VP1. This mutant produces an 8-kilodalton
TABLE 2. Complementation properties of dl(inv)2408E and
dl(inv)2408L"
Plaques formed (PFU/pLg) by complemen-

Complementing
mutant

dIA1209
dlBC865
dIE1226
dlA2459
dlA24115
dlA24205
dl(inv)2408E
Controls
SV40
inv2408
dlA2459
dlE1226
dl(inv)2408E

dl(inv)2408L
or

tation with:

dl(inv)2408E
<103

dl(inv)2408L

<103
2 x 105

<103

3.5 x 104
2.5 x 105
6.5 x 104

2.5 x 104

<103

< 103

<103

<103

<

103

8.5 x 104

3.0 x 105
1.7 x 105
< 103

2.2 x 105
<
<

103
103

a Monolayers of CV-lp cells were transfected with dilutions of dl(in')2408E
di(inv)2408L DNA and 10 ng of complementing mutant DNA per 60-mm

plate.

bMutant dIA2411 lacks 12 bp at 0.497 m.u.; mutant dlA2420 lacks 20 bp at
0.497 m.u. The large T antigen of dlA2411 contains the carboxy terminus of
large T, whereas dIA2420 directs the synthesis of a 18-kilodalton fragment of
large T (65).
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fragment of VP1 (Cole and Goff, unpublished results). A
portion of the inv2408 genome including the EcoRI site was
replaced with an analogous fragment of dlBC865, as described above, to yield mutant dl(inv)2408E, which can
express the early region fusion polypeptide (large T containing the carboxyl terminus of VP1) of inv2408, but not the late
region fusion polypeptide. dlA1209 is another nonviable
SV40 mutant with a 329-bp deletion between 0.650 and 0.587
m.u. (15; Polvino-Bodnar and Cole, unpublished results).
This deletion removes the early mRNA cap site, the initiation site for large T antigen, and the donor splice junction for
large T mRNA. No large T-related polypeptides have been
detected in dlA1209-infected cells (Cole, unpublished results). A portion of the inv2408 genome, including the region
between 0.650 and 0.587 m.u., was replaced by an analogous
fragment of dIA1209 to yield mutant dl(inv)2408L, which can
express the late region fusion polypeptide (VP1 containing
the carboxyl terminus of large T antigen) of inv2408, but not
the early region fusion polypeptide.
These two mutants were examined for their genetic complementation behavior (Table 2). Neither dl(inv)2408E nor
dl(inv)2408L was able to form plaques in CV-lp cells alone.
They were, however, able to complement one another to
permit plaque formation. Furthermore, dl(inv)2408L was
able to complement dIA2459, indicating that the information
missing from dlA2459 large T antigen can be supplied in
trans when this formation is attached to VP1. All of the
control complementations agreed with predicted results:
dl(inv)2408E and dl(inv)2408L were both able to complement
dlE1226, which produces a defective VP2 (15), indicating
that VP2 expression is normal in both mutants; dl(inv)2408L
was unable to complement dlA1209 because it could not
express large T antigen, but was able to complement dlBC865
since the VP1-T antigen fusion polypeptide could perform
the functions of VP1; dl(inv)2408E was unable to complement dlBC865, since it could not express VP1, and was
unable to complement dlA1209 or dlA2411, since it could not
produce a large T antigen providing all of the functions of
large T. We conclude that the carboxyl-terminal 26 amino
acids, transferred to VP1 in inv2408 and dl(inv)2408L, constitute a separable functional domain of SV40 large T antigen.
Mutant dlA2459 can grow in some African green monkey
kidney cell lines. Confluent monolayers of CV-lp, BSC-1, or
Vero cells were transfected with dIA2459 or wild-type DNA.
We found that dlA2459 was able to form plaques on BSC-1
and Vero cells; wild-type SV40 formed plaques on all three
cell lines. The plaques formed in BSC-1 and Vero cells were
approximately half the size of wild-type plaques formed in
those cells. No plaques appeared in CV-lp cells transfected
with dlA2459 DNA, even after 40 days.
DISCUSSION
The large T antigen of SV40 is a multifunctional protein
and may therefore contain multiple functional domains.
Studies with mutants and monoclonal antibodies demonstrate that some of the properties of large T antigen require
different regions of the protein. The ATPase activity of T
antigen can be inhibited specifically by monoclonal antibodies that recognize sequences encoded between 0.33 and 0.27
m.u. (11). The portion of T antigen encoded by sequences
between 0.50 and 0.43 m.u. has been implicated in the
binding of large T antigen to the SV40 origin of DNA
replication (12, 48, 56). The carboxyl-terminal 35 amino
acids of large T are sufficient for normal levels of adenovirus
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helper function (14, 23, 47). We and others have isolated and
characterized many SV40 mutants with deletions in the A
gene, encoding large T antigen (12, 14, 15, 46, 65, 66). These
include mutants lacking ATPase activity, but retaining binding to the SV40 origin, mutants unable to bind to the SV40
origin, but retaining a wild-type level of ATPase activity,
and mutants with drastically reduced levels of adenovirus
helper function, but which are still completely viable. Therefore, at least three separate properties of T antigen have
been localized to different regions of the protein.
We described previously (66) a mutant of SV40, dlA2459,
lacking 14 bp at 0.193 m.u. The large T antigen encoded by
dlA2459 lacks the carboxyl-terminal 35 amino acids and
contains 3 new amino acids in their place. This mutant is
capable of viral DNA replication, but is unable to form
plaques on CV-lp monolayers. These results demonstrate
that a late function, required after the onset of viral DNA
replication, is performed by large T antigen.
In this report, we have further investigated the defect of
dlA2459. Our results indicate that the block to productive
infection by dlA2459 occurred after transcription and before
translation of late mRNA. The defect of dlA2459 was very
similar to the defect of human adenoviruses when they are
grown in CV-1 cells. Adenovirus late mRNAs are produced,
though at a level approximately 10% of that present in
adenovirus-infected human cells (5); production of some
capsid proteins (e.g., fiber) is reduced by as much as
100-fold. Since the deletion in dlA2459 affects that portion of
large T antigen which provides adenovirus helper function
(14, 23, 47) and the defect of dIA2459 resembles that of
adenoviruses in monkey cells, we conclude that productive
infection of CV-1 cells by SV40 requires the helper function.
This function can be provided by intracistronic complementation by any SV40 mutant whose large T antigen contains
the information missing from dlA2459 large T antigen (65)
and by mutant dl(inv)2408L, which contains this information
transposed to the carboxyl terminus of VP1. This indicates
that the helper function information of large T is a separable
functional domain.
A large number of viable mutants with deletions near the
3' end of the SV40 early region have been described (1, 15,
22, 25, 44, 45, 66). In all but one of these mutants, the
deletion is located upstream from the deletion of dIA2459
and is a multiple of 3 bp. Thus, these mutant large T antigens
contain the residues missing from dlA2459 large T antigen.
Many of these mutants show normal levels of adenovirus
helper function. The other mutant, d11265, lacks the carboxylterminal 9 amino acids and contains 4 different residues in
their place (67). This mutant shows a substantially reduced
but measurable level (7%) of helper function (14). Therefore,
productive infection of CV-1 cells by SV40 requires only a
low level of adenovirus helper function. Of mutants with
lesions in this region, only dlA2459 is completely defective
for adenovirus helper function (66). In this paper, we have
shown that a sufficient amount of the function was provided
when only the 26 carboxyl-terminal residues were transposed to VP1. Since productive infection by SV40 requires
only a low level of helper function, we cannot tell whether
the 26 carboxyl-terminal residues provided wild-type levels
of helper function. Mutant inv2408 provided little or no
helper function to coinfecting adenovirus (Cole, unpublished
results). However, in inv2408, helper function becomes a
late SV40 function. Since, adenoviruses effectively inhibit
both cellular and SV40 late protein synthesis (4, 29, 55), this
probably accounts for our inability to measure helper function activity in inv2408-infected cells.

422

TORNOW ET AL.

The genetic analysis of the altered genes in inv2408
supports the idea that some or all of the residues deleted in
dlA2459 large T define a separate domain. Although inv2408
was viable, it grew more slowly than the wild type. To
determine the genetic potentials of the two altered proteins,
the altered genes were separated from one another. The
results of complementation analyses indicated that the altered VP1 of inv2408 was a functional capsid protein, since
dl(inv)2408L could complement dlBC865, a mutant which
produces a defective VP1 (Table 2). However, the plaques
enlarged at a significantly slower rate than those generated
by control complementation [plaques formed by dl(inv)2408L
and dlBC865 were not visible until 10 to 12 days after
infection; plaques formed by coinfection with d1BC865 and
dIA1209 (which encodes a wildtype VP1) were visible 7 days
after infection]. This demonstrated that the altered VP1,
although not completely defective, was impaired. Since
inv2408 DNA replication proceeded with the same kinetics
as wild-type SV40, this suggests that the slower growth
rate of inv2408 was caused primarily by a partially impaired

VP'.
It is not known whether oligomerization of T antigen is
required for it to perform all of its functions. It is possible
that oligomerization occurs as a consequence of the binding
of T antigen monomers to DNA and that mutant monomers
unable to remain oligomerized after dissociation from DNA
might still possess full activity. The monomer fraction of T
antigen displays both ATPase and specific DNA binding (8,
20). Our finding that the helper function of large T can be
provided by a VP1 polypeptide carrying the carboxyl-terminal 26 residues of large T antigen suggests that oligomerization of large T is not required for this function. However,
since VP1 does oligomerize in the formation of the viral
capsid, the possibility that the helper activity of inv2408
requires the formation of VP1 oligomers cannot be eliminated.
SV40 large T antigen and the adenovirus 72-kilodalton
DNA-binding protein show important similarities. Both are
involved in DNA replication and in regulation of transcription (17, 33, 43). Although adenoviruses cannot grow productively in monkey cells, adenovirus mutants capable of
productive infection of monkey cells can be isolated (3, 36,
38). The lesions in these host range mutants map to the
72-kilodalton DNA-binding protein and are located at a site
in the polypeptide distant from the mutation sites of mutants
affecting the replication and transcriptional regulation activities of the polypeptide (53). Thus, for both SV40 and the
human adenoviruses, a separate domain of a major DNAbinding and regulatory polypeptide is involved in permitting
the virus to grow productively in monkey cells. In both
cases, sites of phosphorylation are located in the helper
function region of the polypeptide. It will be interesting to
determine whether expression of the adenovirus host range
mutant 72-kilodalton DNA-binding protein will permit the
growth of SV40 mutants such as dlA2459 in CV-1 or CV-lp
cells in a manner analogous to the role played by the
carboxyl terminus of large T antigen in permitting productive adenovirus infection of CV-1 cells.
The helper function activity of large T is provided by the
only part of large T showing no homology with polyomavirus
(Fig. 1). This suggests that this information entered the SV40
genome after the evolutionary separation of SV40 and
polyomavirus. Although the large T antigen of the human
papovavirus, BKV, shows homology to this portion of SV40
large T (57), the homology is much less than that between
the remainder of SV40 and BK large T antigens.
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The function defined by dlA2459 is essential only in some
green monkey kidney cell lines. Although dlA2459 could not
form plaques in CV-lp cells, plaques were formed at wildtype efficiency in both BSC-1 and Vero cells. Therefore,
dlA2459 is a host range mutant. CV-lp, Vero, and BSC-1
cells are independent lines all derived from kidneys of
Cercopithecus aethiops, but may have considerably different cellular biology. Human adenoviruses are able to
grow in Vero cells without an SV40 helper (18). We found
that adenovirus type 2 was also able to grow in BSC-1 cells
(Cole, unpublished results). Eron et al. (18) reported that
adenoviruses could not grow in BSC-1 cells. This discrepancy could reflect substantial differences between the BSC-1
line they used and the one we currently use. Another SV40
mutant, isolated by Pipas et al. (46), lacks 80 bp between
0.196 and 0.181 m.u.; it forms plaques in BSC-1 cells, but not
in CV-lp cells (Pipas, personal communication). This suggests that the host range behavior of these mutants is a
general property of mutants whose large T antigens lack
carboxyl terminal information. At present, we do not understand the molecular basis for the host range behavior, but it
may indicate that the carboxyl-terminal domain of large T
antigen is involved in determining the tissue or species
growth range (or both) of SV40.
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